Financial reports

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020

Ascelia Pharma company presentation March 2021

• 2021-05-12Quarterly Report Q1 2021: US office opened in preparation of launch
• 2021-05-05Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021
• 2021-04-30Number of shares and votes in Ascelia Pharma AB
• 2021-04-15Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm
• 2021-04-13Bulletin from the extraordinary general meeting in Ascelia Pharma AB

• August 19 @ 08:00

  Half-year report 2021 (April-June 2021)

• September 1

  Pareto Healthcare Conference – 1 September 2021 (Virtual)

• October 5 @ 11:00 - 11:45

  Danske Bank Event Series: Life Science, Launch Phase

• November 4 @ 08:00

  Interim report 9M (January-September 2021)

• November 30 - December 2

  Danske Bank’s Winter Seminar